Chief Strategy Officer

Member Board of Directors

President and Chief Medical Officer

Co-Founder and Chief Medical Officer

Co-Founder

Professor of Medicine and Vice Chair, Division of Gastroenterology and Hepatology

Biotech Executive, Board Member, Physician Scientist, Serial Entrepreneur, Professor, Key Opinion Leader, and Academic Leader

William Sandborn

Mirador Therapeutics

Chief Legal Officer

General Counsel

Senior Corporate Counsel

Associate

Business Analyst

Legal Executive

Tim Andrews

Chief Financial Officer

Member of the Board of Advisors

SVP of Finance

VP of Finance/Controller

CFO, Mirador Therapeutics, Inc.

Vika Brough

Board Member

Chief Business Officer

SVP, Corporate Business Development and Investor Relations

Strategic Advisor

SVP, Chief Strategy Officer

Corporate Strategy Executive I Biotech Entrepreneur I Board Member

Jordan Zwick

Chief Scientific Officer

Manager

Chief Scientific Officer and Head of R&D

Chief Technology Officer and Head of R&D

Associate Director - Drug Product Formulation and Manufacturing

Group Leader

Scientist - Late Stage Formulation

Senior Scientist - Protein Formulation and Fill-Finish

Scientist - Non-viral Gene Delivery

Ph.D. Student - Cell Biology

Biotech executive, R&D

Olivier Laurent

Chief Medical Officer

Biotech Executive, Physician Scientist, Chief Medical Officer, Board Member

Allison Luo

Chief People Officer

EVP & Chief Human Resources Officer

Chief Human Resources Officer

Vice President, Human Resources

Chief People Officer at Mirador Therapeutics, Inc.,              Independent public board member

Nori Ebersole

Chairman and Chief Executive Officer

Venture Partner

Chairman of the Board

President

Chairman and Chief Executive Officer of Mirador Therapeutics I Chairman of Apogee Therapeutics I EY Entrepreneur of the Year

Mark McKenna

Executive Director Protein Engineering

Head of Antibody Engineering

Life Science Consultant

Director, Immunotherapeutic Design, Cancer Immunology Discovery (CID)

Guest Professor

Assistant Professor

Postdoctoral Fellow

Graduate Student

Head of Protein Engineering/ Structural Immunologist

Dirk Zajonc

Associate Director, Precision Genetics

Associate Director, Translational Genetics (formerly Functional Genomics)

Principal Scientist, Functional Genomics

Principal Scientist, Human Genetics

Senior Scientist, Human Genetics

Scientist, Statistical Genetics

Postdoctoral Research Fellow, Cardiovascular Genetics

Computational & Translational Genetics Leader | Coach | Board Member | DEI Advocate

Khanh-Dung Nguyen

Executive Director

Director, Cancer Immunology Discovery

Senior Research Investigator II, Immuno Oncology Discovery

Team Lead, Immuno-Oncology Biology and Immuno-Oncology Resistance Biology

Project Scientist/Instructor - Tumor Microenvironment

Postdoctoral fellow, Laboratory of 2019 Lasker Award winner Professor Max Cooper

Executive Director, Immunology, Mirador Therapeutics

Murali Gururajan

Mirador is a biotechnology company focused on developing precision therapies for immune-mediated diseases.

Mirador

Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA. 

Photo	Title	Links
	William Sandborn Chief Strategy Officer
	Tim Andrews Chief Legal Officer
	Vika Brough Chief Financial Officer
	Jordan Zwick Chief Business Officer
	Olivier Laurent Chief Scientific Officer
	Allison Luo Chief Medical Officer
	Nori Ebersole Chief People Officer
	Mark McKenna Chairman and Chief Executive Officer
	Dirk Zajonc Executive Director Protein Engineering
	Khanh-Dung Nguyen Associate Director, Precision Genetics
	Murali Gururajan Executive Director

COM:MIRADORTX